Ahmed, M., Kimura, K., Soliman, M., Yamaji, D., Okamatsu-Ogura, Y., Makondo, K., Inanami, O., & Saito, M. (2007). Effects of Leptin and Tumor Necrosis Factor-α on Degranulation and Superoxide Production of Polymorphonuclear Neutrophils from Holstein Cows. J. Vet. Med. Sci, 69(2). http://rsb.info.nih.gov/nih-image/
Angelucci, F., Mirabella, M., Caggiula, M., Frisullo, G., Patanella, K., Sancricca, C., Nociti, V., Tonali, P. A., & Batocchi, A. P. (2005). Evidence of involvement of leptin and IL-6 peptides in the action of interferon-beta in secondary progressive multiple sclerosis. Peptides, 26(11), 2289–2293. https://doi.org/10.1016/J.PEPTIDES.2005.03.037
Article CAS PubMed Google Scholar
Baecher-Allan, C., Kaskow, B. J., & Weiner, H. L. (2018). Multiple sclerosis: Mechanisms and immunotherapy. Neuron, 97(4), 742–768. https://doi.org/10.1016/J.NEURON.2018.01.021
Article CAS PubMed Google Scholar
Baharnoori, M., Wilson, R., Saxena, S., Gonzalez, C. T., Sotiropoulos, M. G., Keyhanian, K., Healy, B. C., & Chitnis, T. (2021). Altered adipokine levels are associated with dimethyl fumarate treatment in multiple sclerosis patients. Multiple Sclerosis and Related Disorders. https://doi.org/10.1016/j.msard.2021.103311
Bapat, S. P., Whitty, C., Mowery, C. T., Liang, Y., Yoo, A., Jiang, Z., Peters, M. C., Zhang, L. J., Vogel, I., Zhou, C., Nguyen, V. Q., Li, Z., Chang, C., Zhu, W. S., Hastie, A. T., He, H., Ren, X., Qiu, W., Gayer, S. G., … & Marson, A. (2022). Obesity alters pathology and treatment response in inflammatory disease. Nature, 604(7905), 337–342. https://doi.org/10.1038/s41586-022-04536-0
Batocchi, A. P., Rotondi, M., Caggiula, M., Frisullo, G., Odoardi, F., Nociti, V., Carella, C., Tonali, P. A., & Mirabella, M. (2003). Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta. Journal of Neuroimmunology, 139(1–2), 150–154. https://doi.org/10.1016/S0165-5728(03)00154-1
Article CAS PubMed Google Scholar
Biström, M., Hultdin, J., Andersen, O., Alonso-Magdalena, L., Jons, D., Gunnarsson, M., Vrethem, M., & Sundström, P. (2021). Leptin levels are associated with multiple sclerosis risk. Multiple Sclerosis Journal, 27(1), 19–27. https://doi.org/10.1177/1352458520905033
Article CAS PubMed Google Scholar
Blüher, M., & Mantzoros, C. S. (2015). From leptin to other adipokines in health and disease: Facts and expectations at the beginning of the 21st century. Metabolism. https://doi.org/10.1016/j.metabol.2014.10.016
Bove, R., Musallam, A., Xia, Z., Baruch, N., Messina, S., Healy, B. C., & Chitnis, T. (2016). Longitudinal BMI trajectories in multiple sclerosis: Sex differences in association with disease severity. Multiple Sclerosis and Related Disorders, 8, 136–140. https://doi.org/10.1016/J.MSARD.2016.05.019
Article CAS PubMed Google Scholar
Briggs, F. B. S., Yu, J. C., Davis, M. F., Jiangyang, J., Fu, S., Parrotta, E., Gunzler, D. D., & Ontaneda, D. (2018). Multiple sclerosis risk factors contribute to onset heterogeneity. Multiple Sclerosis and Related Disorders. https://doi.org/10.1016/j.msard.2018.12.007
Bruno, A., Conus, S., Schmid, I., & Simon, H.-U. (2005). Apoptotic pathways are inhibited by leptin receptor activation in neutrophils. The Journal of Immunology, 174(12), 8090–8096. https://doi.org/10.4049/JIMMUNOL.174.12.8090
Article CAS PubMed Google Scholar
Carvalho-Tavares, J., Hickey, M. J., Hutchison, J., Michaud, J., Sutcliffe, I. T., & Kubes, P. (2000). A role for platelets and endothelial selectins in tumor necrosis factor-alpha-induced leukocyte recruitment in the brain microvasculature. Circulation Research, 87(12), 1141–1148. https://doi.org/10.1161/01.RES.87.12.1141
Article CAS PubMed Google Scholar
Chai, J., & Song, Q. (2014). Quantitative and multiplexed study of endothelial cell inflammation. Cell Biochemistry and Biophysics, 70(3), 1783–1790. https://doi.org/10.1007/S12013-014-0129-8
Article CAS PubMed Google Scholar
Chitnis, T., Graves, J., Weinstock-Guttman, B., Belman, A., Olsen, C., Misra, M., Aaen, G., Benson, L., Candee, M., Gorman, M., Greenberg, B., Krupp, L., Lotze, T., Mar, S., Ness, J., Rose, J., Rubin, J., Schreiner, T., Tillema, J., … & Waubant, E. (2016). Distinct effects of obesity and puberty on risk and age at onset of pediatric MS. Annals of Clinical and Translational Neurology, 3(12), 897–907. https://doi.org/10.1002/ACN3.365
Choi, I. Y., Piccio, L., Childress, P., Bollman, B., Ghosh, A., Brandhorst, S., Suarez, J., Michalsen, A., Cross, A. H., Morgan, T. E., Wei, M., Paul, F., Bock, M., & Longo, V. D. (2016). A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms. Cell Reports, 15(10), 2136–2146. https://doi.org/10.1016/J.CELREP.2016.05.009
Article CAS PubMed Google Scholar
Cinkir, U., Bir, L. S., Topsakal, S., Cicek, E. A., & Tekin, S. (2021). Investigation of blood leptin and adropin levels in patients with multiple sclerosis A CONSORT-clinical study. Medicine (United States). https://doi.org/10.1097/MD.0000000000027247
Çoban, A., Çevik, D., Özyurt, S., Gencer, M., Tüzün, E., & Türkoʇlu, R. (2015). The association between obesity and oligoclonal band formation in multiple sclerosis patients. Obesity Research and Clinical Practice, 9(5), 533–535. https://doi.org/10.1016/j.orcp.2015.07.001
Considine, R. V., Sinha, M. K., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Nyce, M. R., Ohannesian, J. P., Marco, C. C., McKee, L. J., Bauer, T. L., & Caro, J. F. (1996). Serum immunoreactive-leptin concentrations in normal-weight and obese humans. The New England Journal of Medicine, 334(5), 292–295. https://doi.org/10.1056/NEJM199602013340503
Article CAS PubMed Google Scholar
Correale, J., & Marrodan, M. (2022). Multiple sclerosis and obesity: The role of adipokines. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2022.1038393
Article PubMed PubMed Central Google Scholar
Cortese, M., Yuan, C., Chitnis, T., Ascherio, A., & Munger, K. L. (2017). No association between dietary sodium intake and the risk of multiple sclerosis. Neurology, 89(13), 1322–1329. https://doi.org/10.1212/WNL.0000000000004417
Article CAS PubMed PubMed Central Google Scholar
Cowley, M. A., Smart, J. L., Rubinstein, M., Cerdán, M. G., Diano, S., Horvath, T. L., Cone, R. D., & Low, M. J. (2001). Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature, 411(6836), 480–484. https://doi.org/10.1038/35078085
Article CAS PubMed Google Scholar
Dahlman, I., Elsen, M., Tennagels, N., Korn, M., Brockmann, B., Sell, H., Eckel, J., & Arner, P. (2012). Functional annotation of the human fat cell secretome. Archives of Physiology and Biochemistry, 118(3), 84–91. https://doi.org/10.3109/13813455.2012.685745
Article CAS PubMed Google Scholar
Dargahi, N., Katsara, M., Tselios, T., Androutsou, M. E., De Courten, M., Matsoukas, J., & Apostolopoulos, V. (2017). Multiple Sclerosis: Immunopathology and treatment update. Brain Sciences, 7(7), 78. https://doi.org/10.3390/BRAINSCI7070078
Article PubMed PubMed Central Google Scholar
Davanzo, G. G., Castro, G., Monteiro, L. B., Castelucci, B. G., Jaccomo, V. H., da Silva, F. C., Marques, A. M., Francelin, C., de Campos, B. B., de Aguiar, C. F., Joazeiro, P. P., Consonni, S. R., Farias, A. S., & Moraes-Vieira, P. M. (2023). Obesity increases blood-brain barrier permeability and aggravates the mouse model of multiple sclerosis. Multiple Sclerosis and Related Disorders, 72, 104605. https://doi.org/10.1016/J.MSARD.2023.104605
Article CAS PubMed Google Scholar
Dayakar, A., Chandrasekaran, S., Veronica, J., & Maurya, R. (2016). Leptin induces the phagocytosis and protective immune response in Leishmania donovani infected THP-1 cell line and human PBMCs. Experimental Parasitology, 160, 54–59. https://doi.org/10.1016/J.EXPPARA.2015.12.002
Article CAS PubMed Google Scholar
de Candia, P., & Matarese, G. (2018). Leptin and ghrelin: Sewing metabolism onto neurodegeneration. Neuropharmacology, 136(Pt B), 307–316. https://doi.org/10.1016/J.NEUROPHARM.2017.12.025
Fisniku, L. K., Chard, D. T., Jackson, J. S., Anderson, V. M., Altmann, D. R., Miszkiel, K. A., Thompson, A. J., & Miller, D. H. (2008). Gray matter atrophy is related to long-term disability in multiple sclerosis. Annals of Neurology, 64(3), 247–254. https://doi.org/10.1002/ANA.21423
Fitzgerald, K. C., Vizthum, D., Henry-Barron, B., Schweitzer, A., Cassard, S. D., Kossoff, E., Hartman, A. L., Kapogiannis, D., Sullivan, P., Baer, D. J., Mattson, M. P., Appel, L. J., & Mowry, E. M. (2018). Effect of intermittent vs. daily calorie restriction on changes in weight and patient-reported outcomes in people with multiple sclerosis. Multiple Sclerosis and Related Disorders, 23, 33–39. https://doi.org/10.1016/J.MSARD.2018.05.002
Article PubMed PubMed Central Google Scholar
Flores-Cordero, J. A., Pérez-Pérez, A., Jiménez-Cortegana, C., Alba, G., Flores-Barragán, A., & Sánchez-Margalet, V. (2022). Obesity as a risk factor for dementia and Alzheimer’s Disease: The role of leptin. International Journal of Molecular Sciences. https://doi.org/10.3390/IJMS23095202
Comments (0)